{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:10:45Z","timestamp":1786997445051,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["88887.688764\/2022\/00"],"award-info":[{"award-number":["88887.688764\/2022\/00"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305346\/2024-5"],"award-info":[{"award-number":["305346\/2024-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2013\/08135-2"],"award-info":[{"award-number":["2013\/08135-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2022\/13366-2"],"award-info":[{"award-number":["2022\/13366-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.thromres.2025.109559","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:59:16Z","timestamp":1764403156000},"page":"109559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Platelets display immunophenotypic alterations and dysregulated transcriptomic signature in Philadelphia-negative myeloproliferative neoplasms"],"prefix":"10.1016","volume":"257","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6660-6369","authenticated-orcid":false,"given":"Vitor Leonardo","family":"Bassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poliana Carina","family":"Paolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian Maria Garcia","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Rossetto","family":"de Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Fernando Princi","family":"Chaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia Vianna Bonini","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Menezes","family":"Bonaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela","family":"de Freitas Martins Fel\u00edcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena Lobo","family":"de Figueiredo-Pontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fab\u00edola Atti\u00e9","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.thromres.2025.109559_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/jamaoncol.2015.89","article-title":"Myeloproliferative neoplasms: a contemporary review","volume":"1","author":"Tefferi","year":"2015","journal-title":"JAMA Oncol."},{"issue":"24","key":"10.1016\/j.thromres.2025.109559_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417383","article-title":"Myeloproliferative neoplasms: contemporary review and molecular landscape","volume":"24","author":"Mahmud","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.thromres.2025.109559_bb0015","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of Haematolymphoid Tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"16","key":"10.1016\/j.thromres.2025.109559_bb0020","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood.2022017578","article-title":"Genetic basis and molecular profiling in myeloproliferative neoplasms","volume":"141","author":"Luque Paz","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2025.109559_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.665037","article-title":"Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms","volume":"11","author":"Cominal","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109559_bb0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.htct.2017.12.003","article-title":"Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation","volume":"40","author":"Cacemiro","year":"2018","journal-title":"Hematol. Transfus. Cell Ther."},{"issue":"5","key":"10.1016\/j.thromres.2025.109559_bb0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/MOH.0000000000000669","article-title":"Still a burning question: the interplay between inflammation and fibrosis in myeloproliferative neoplasms","volume":"28","author":"Gleitz","year":"2021","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.thromres.2025.109559_bb0040","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/606819","article-title":"Inflammation as a driver of clonal evolution in myeloproliferative neoplasm","volume":"2015","author":"Fleischman","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"9","key":"10.1016\/j.thromres.2025.109559_bb0045","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3390\/cells9092136","article-title":"Cytokine profiling in myeloproliferative neoplasms: overview on phenotype correlation, outcome prediction, and role of genetic variants","volume":"9","author":"Masselli","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.thromres.2025.109559_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00277-016-2826-4","article-title":"Management of extreme thrombocytosis in myeloproliferative neoplasms: an international physician survey","volume":"96","author":"Koren-Michowitz","year":"2017","journal-title":"Ann. Hematol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109559_bb0055","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11899-021-00630-8","article-title":"Novel pathophysiological mechanisms of thrombosis in myeloproliferative neoplasms","volume":"16","author":"Reeves","year":"2021","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"9","key":"10.1016\/j.thromres.2025.109559_bb0060","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1182\/blood.2020008043","article-title":"Clinical insights into the origins of thrombosis in myeloproliferative neoplasms","volume":"137","author":"Moliterno","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2025.109559_bb0065","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/s41375-021-01170-z","article-title":"Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms","volume":"35","author":"Guy","year":"2021","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.thromres.2025.109559_bb0070","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/jth.14754","article-title":"Association between myelofibrosis and thromboembolism: a population-based retrospective cohort study","volume":"18","author":"Saliba","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109559_bb0075","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3389\/fimmu.2019.01373","article-title":"Platelets as mediators of thromboinflammation in chronic myeloproliferative neoplasms","volume":"10","author":"Marin Oyarz\u00fan","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109559_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100060","article-title":"Platelet function studies in myeloproliferative neoplasms patients with Calreticulin or JAK2V617F mutation","volume":"7","author":"Guy","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2025.109559_bb0085","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.3390\/ijms26062756","article-title":"The role of platelet dysfunctions in the pathogenesis of the hemostatic-coagulant system imbalances","volume":"26","author":"Badulescu","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.thromres.2025.109559_bb0090","doi-asserted-by":"crossref","first-page":"9172","DOI":"10.1038\/s41598-023-36266-2","article-title":"Platelets from patients with myeloproliferative neoplasms have increased numbers of mitochondria that are hypersensitive to depolarization by thrombin","volume":"13","author":"Ross","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.thromres.2025.109559_bb0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ajh.21338","article-title":"Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden","volume":"84","author":"Arellano-Rodrigo","year":"2009","journal-title":"Am. J. Hematol."},{"issue":"10","key":"10.1016\/j.thromres.2025.109559_bb0100","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1161\/ATVBAHA.120.314760","article-title":"Platelet dysfunction and thrombosis in JAK2V617F-mutated primary myelofibrotic mice","volume":"40","author":"Matsuura","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109559_bb0105","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172256","article-title":"Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms","volume":"134","author":"He","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.thromres.2025.109559_bb0110","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1007\/s00277-024-06023-0","article-title":"Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as novel prognostic biomarkers in BCR-ABL negative myeloproliferative neoplasms","volume":"103","author":"Zvetkovi\u0107","year":"2024","journal-title":"Ann. Hematol."},{"issue":"6","key":"10.1016\/j.thromres.2025.109559_bb0115","first-page":"606","article-title":"Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are predictors of heart failure","volume":"105","author":"Durmus","year":"2015","journal-title":"Arq. Bras. Cardiol."},{"issue":"9","key":"10.1016\/j.thromres.2025.109559_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23935","article-title":"Distribution and reference interval establishment of neutral-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in Chinese healthy adults","volume":"35","author":"Wang","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.thromres.2025.109559_bb0125","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.3390\/jcm13154459","article-title":"Systemic inflammatory index in polycythemia vera and its prognostic implications","volume":"13","author":"Krecak","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.thromres.2025.109559_bb0130","doi-asserted-by":"crossref","first-page":"12539","DOI":"10.1038\/s41598-023-39077-7","article-title":"Systemic inflammatory indices for predicting prognosis of myelofibrosis","volume":"13","author":"Ersal","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.thromres.2025.109559_bb0135","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jtha.2024.11.029","article-title":"Impaired hemostatic and immune functions of platelets after acute thrombocytopenia","volume":"23","author":"Pirabe","year":"2025","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109559_bb0140","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6591717","article-title":"Platelet-rich plasma: the choice of activation method affects the release of bioactive molecules","volume":"2016","author":"Cavallo","year":"2016","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.thromres.2025.109559_bb0145","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-0609.2011.01618.x","article-title":"Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis","volume":"87","author":"Skov","year":"2011","journal-title":"Eur. J. Haematol."},{"issue":"43","key":"10.1016\/j.thromres.2025.109559_bb0150","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.thromres.2025.109559_bb0155","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biological study of five human vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.thromres.2025.109559_bb0160","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221097969","article-title":"Thrombotic and hemorrhagic issues associated with myeloproliferative neoplasms","volume":"28","author":"Papageorgiou","year":"2022","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109559_bb0165","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1182\/blood.2019001113","article-title":"Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population","volume":"134","author":"Cordua","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2025.109559_bb0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/M17-0028","article-title":"Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms: a population-based cohort study","volume":"168","author":"Hultcrantz","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109559_bb0175","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s12872-020-01663-2","article-title":"P-selectin (CD62P) and soluble TREM-like transcript-1 (sTLT-1) are associated with coronary artery disease: a case control study","volume":"20","author":"Shen","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"issue":"20","key":"10.1016\/j.thromres.2025.109559_bb0180","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.3390\/jcm12206430","article-title":"Increasing soluble P-selectin levels predict higher peripheral atherosclerotic plaque progression","volume":"12","author":"Sommer","year":"2023","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.thromres.2025.109559_bb0185","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00001721-200404000-00006","article-title":"Assessment of platelet activation in myeloproliferative disorders with complementary techniques","volume":"15","author":"Bermejo","year":"2004","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"2","key":"10.1016\/j.thromres.2025.109559_bb0190","first-page":"373","article-title":"Expression of CD markers in JAK2V617F positive myeloproliferative neoplasms: prognostic significance","volume":"12","author":"Shahrabi","year":"2018","journal-title":"Oncol. Rev."},{"issue":"1","key":"10.1016\/j.thromres.2025.109559_bb0195","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12185-013-1475-9","article-title":"JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients","volume":"99","author":"Coucelo","year":"2014","journal-title":"Int. J. Hematol."},{"issue":"72","key":"10.1016\/j.thromres.2025.109559_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.272re3","article-title":"CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior","volume":"2","author":"Silverstein","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.thromres.2025.109559_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1079076","article-title":"Role of CD36 in cancer progression, stemness, and targeting","volume":"10","author":"Guerrero-Rodr\u00edguez","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"21","key":"10.1016\/j.thromres.2025.109559_bb0210","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1182\/blood-2016-11-750133","article-title":"Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions","volume":"129","author":"Yang","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2025.109559_bb0215","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2141.1995.tb05357.x","article-title":"Increased platelet CD36 constitutes a common marker in myeloproliferative disorders","volume":"91","author":"Thibert","year":"1995","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.thromres.2025.109559_bb0220","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1016\/j.thromres.2010.08.002","article-title":"Flow cytometry-evaluated platelet CD36 expression, reticulated platelets and platelet microparticles in essential thrombocythaemia and secondary thrombocytosis","volume":"126","author":"Moles-Moreau","year":"2010","journal-title":"Thromb. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2025.109559_bb0225","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1182\/blood-2018-99-115349","article-title":"The importance of CD36 expression in evaluation of thrombotic risk in patients with myeloproliferative neoplasms","volume":"132","author":"Popov","year":"2018","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.thromres.2025.109559_bb0230","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1538-7836.2011.04416.x","article-title":"Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein","volume":"9","author":"Nergiz-Unal","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2025.109559_bb0235","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1172\/JCI8574","article-title":"Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species","volume":"105","author":"Podrez","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.thromres.2025.109559_bb0240","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI14006","article-title":"CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism","volume":"108","author":"Febbraio","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.thromres.2025.109559_bb0245","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.yexcr.2008.09.020","article-title":"Trafficking and function of the tetraspanin CD63","volume":"315","author":"Pols","year":"2009","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.thromres.2025.109559_bb0250","doi-asserted-by":"crossref","first-page":"20300","DOI":"10.1038\/s41598-021-99777-w","article-title":"Exosomal CD63 in critically ill patients with sepsis","volume":"11","author":"Im","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.thromres.2025.109559_bb0255","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1373\/clinchem.2005.057414","article-title":"P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction","volume":"52","author":"van der Zee","year":"2006","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.thromres.2025.109559_bb0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/09537100310001644024","article-title":"Increased platelet CD63 and P-selectin expression persist in atherosclerotic ischemic stroke","volume":"15","author":"Cha","year":"2004","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.thromres.2025.109559_bb0265","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1532\/IJH97.E0316","article-title":"Markers of endothelial and in vivo platelet activation in patients with essential thrombocythemia and polycythemia vera","volume":"79","author":"Karakantza","year":"2004","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.thromres.2025.109559_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.825892","article-title":"Platelets as key factors in inflammation: focus on CD40L\/CD40","volume":"13","author":"Cognasse","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.thromres.2025.109559_bb0275","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/ATVBAHA.114.305127","article-title":"Platelet CD40L modulates thrombus growth via phosphatidylinositol 3-kinase \u03b2, and not via CD40 and I\u03baB kinase \u03b1","volume":"35","author":"Kuijpers","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.thromres.2025.109559_bb0280","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0301-472X(02)00921-9","article-title":"CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blasts","volume":"30","author":"Aldinucci","year":"2002","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109559_bb0285","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jtha.2023.08.028","article-title":"Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms","volume":"22","author":"Guy","year":"2024","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2025.109559_bb0290","first-page":"279","article-title":"Platelet dysfunctions in myeloproliferative disorders","volume":"5","author":"Lucchesi","year":"2001","journal-title":"J. Cell. Mol. Med."},{"issue":"11","key":"10.1016\/j.thromres.2025.109559_bb0295","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/s41419-021-04246-x","article-title":"Essential role of zyxin in platelet biogenesis and glycoprotein Ib-IX surface expression","volume":"12","author":"Yan","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.thromres.2025.109559_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1060361","article-title":"Filamin A in platelets: bridging the (signaling) gap between the plasma membrane and the actin cytoskeleton","volume":"9","author":"De Silva","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"5","key":"10.1016\/j.thromres.2025.109559_bb0305","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1182\/blood-2010-09-305433","article-title":"Talin-dependent integrin activation is required for fibrin clot retraction by platelets","volume":"117","author":"Haling","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2025.109559_bb0310","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/cvr\/cvaa016","article-title":"Hepatocyte growth factor-regulated tyrosine kinase substrate is essential for endothelial cell polarity and cerebrovascular stability","volume":"117","author":"Yu","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.thromres.2025.109559_bb0315","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2003-10-3428","article-title":"Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice","volume":"104","author":"Chen","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2025.109559_bb0320","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/metabo12040284","article-title":"PNPLA6\/NTE, an evolutionary conserved phospholipase linked to a group of complex human diseases","volume":"12","author":"Kretzschmar","year":"2022","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.thromres.2025.109559_bb0325","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/jth.15668","article-title":"Activation mechanism dependent surface exposure of cellular factor XIII on activated platelets and platelet microparticles","volume":"20","author":"Somodi","year":"2022","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2025.109559_bb0330","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3324\/haematol.2022.282136","article-title":"The relative importance of platelet integrins in hemostasis, thrombosis and beyond","volume":"108","author":"Janus-Bell","year":"2023","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.thromres.2025.109559_bb0335","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MOH.0000000000000366","article-title":"The ins and outs of endocytic trafficking in platelet functions","volume":"24","author":"Banerjee","year":"2017","journal-title":"Curr. Opin. Hematol."},{"issue":"18","key":"10.1016\/j.thromres.2025.109559_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251810000","article-title":"How protein depletion balances thrombosis and bleeding risk in the context of platelet\u2019s activatory and negative signaling","volume":"25","author":"Montecino-Garrido","year":"2024","journal-title":"Int. J. Mol. Sci."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825003093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825003093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:20:26Z","timestamp":1778664026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825003093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":68,"alternative-id":["S0049384825003093"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109559","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelets display immunophenotypic alterations and dysregulated transcriptomic signature in Philadelphia-negative myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109559"}}